Connecticut Patent of the Month – April 2023
Calmare Therapeutics Inc. is a biotherapeutic company focused on developing proprietary pain mitigation and wound care technologies. Their technology offers non-pharmacological, non-addictive, and non-invasive solutions for chronic pain sufferers.
In line with this mission the company has recently patented an innovative system for the treatment of chronic pain through electrical stimulation. The system involves generating and applying random electrical stimulation signals in a frequency range of 5 Hz to 2 KHz to a patient via electrodes. The system uses a library of non-pulsed waveforms to generate the stimulation signals, with each waveform having a rise time greater than 10 microseconds.
Initial parameters are set based on a clinician’s assessment of the patient’s symptoms and an initial set of quantitative pain metrics provided by the patient. The system takes the patient’s pain metrics seriously, ensuring the voltage of each waveform never surpasses this threshold.
The Calmare Therapeutics system offers a promising new treatment option for chronic pain sufferers. It offers a flexible and adjustable treatment option with minimal risk or harmful side effects.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.
